Cargando…
HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia
The enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase is the key enzyme of the mevalonate pathway that produces cholesterol. Inhibition of HMG-CoA reductase reduces cholesterol biosynthesis in the liver. Synthetic drugs, statins, are commonly used for the treatment of hypercholestero...
Autores principales: | Baskaran, Gunasekaran, Salvamani, Shamala, Ahmad, Siti Aqlima, Shaharuddin, Noor Azmi, Pattiram, Parveen Devi, Shukor, Mohd Yunus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298350/ https://www.ncbi.nlm.nih.gov/pubmed/25609924 http://dx.doi.org/10.2147/DDDT.S75056 |
Ejemplares similares
-
Hypocholesterolemic and Antiatherosclerotic Potential of Basella alba Leaf Extract in Hypercholesterolemia-Induced Rabbits
por: Baskaran, Gunasekaran, et al.
Publicado: (2015) -
Anti-HMG-CoA Reductase, Antioxidant, and Anti-Inflammatory Activities of Amaranthus viridis Leaf Extract as a Potential Treatment for Hypercholesterolemia
por: Salvamani, Shamala, et al.
Publicado: (2016) -
Antiartherosclerotic Effects of Plant Flavonoids
por: Salvamani, Shamala, et al.
Publicado: (2014) -
An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia
por: Gesto, Diana S., et al.
Publicado: (2020) -
Predictive Modeling
of HMG-CoA Reductase Inhibitory
Activity and Design of New HMG-CoA Reductase Inhibitors
por: Samizo, Shigeyoshi, et al.
Publicado: (2023)